scholarly journals Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

2014 ◽  
Vol 73 (3) ◽  
pp. 539-549 ◽  
Author(s):  
Edward Sausville ◽  
Patricia LoRusso ◽  
Michael Carducci ◽  
Judith Carter ◽  
Mary F. Quinn ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Kinase Inhibitor ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study ◽  
Checkpoint Kinase ◽  
Checkpoint Kinase Inhibitor

scholarly journals Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors

2010 ◽  
Vol 67 (2) ◽  
pp. 305-314 ◽  
Author(s):  
Anne M. Traynor ◽  
Maureen Hewitt ◽  
Glenn Liu ◽  
Keith T. Flaherty ◽  
Jason Clark ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Kinase Inhibitor ◽  
Aurora Kinase ◽  
Adult Patients ◽  
Advanced Solid Tumors ◽  
Aurora Kinase Inhibitor ◽  
Dose Escalation Study

A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

2012 ◽  
Vol 18 (9) ◽  
pp. 2658-2667 ◽  
Author(s):  
Klaus Mross ◽  
Annette Frost ◽  
Simone Steinbild ◽  
Susanne Hedbom ◽  
Martin Büchert ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study

scholarly journals Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

2009 ◽  
Vol 66 (4) ◽  
pp. 669-680 ◽  
Author(s):  
Francisco Robert ◽  
Alan Sandler ◽  
Joan H. Schiller ◽  
Glenn Liu ◽  
Karen Harper ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study
Sign in / Sign up

Export Citation Format

Share Document